Hikal Share Price
Small Cap | Pharmaceuticals and health care | NSE: HIKAL | BSE: 524735
₹400.85 -24.80 (-5.83 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 425.65
High (₹) 429.60
Low (₹) 397.20
Prev. Close (₹) 425.65
Volume 6,87,972
VWAP (₹) 347.44
ROCE (%) 8.77
Industry P/E 46.49
TTM P/E 66.26
P/B Ratio 4.16
Market Cap (₹) Cr.4,942.51
Dividend Yield (%)0.30
EPS (₹) 5.64
ROE5.86%
Sales Growth (%) -11.79
Profit Growth (%)-11.20
Day Range
429.60429.60
52 Week Range
268.05464.50
Historical Returns
Returns (6M)
16.27 %
Returns (1Y)
38.32 %
Returns (3Y)
-7.03 %
Returns (5Y)
392.14 %
Returns (6M)
16.27 %
Returns (1Y)
38.32 %
Returns (3Y)
-7.03 %
Returns (5Y)
392.14 %
SWOT Analysis
- Book value per share improving over the last 2 years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 36.06
MFI 46.35
ATR 14.93
Commodity Channel Index -51.97
ROC125 6.66
ROC21 0.86
Williams %R -51.60
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 356.76 | 362.83 | 371.71 | 347.88 | 341.81 | 332.93 | 326.86 |
Week Ago | 362.81 | 367.98 | 373.96 | 356.83 | 351.66 | 345.68 | 340.51 |
Month Ago | 347.66 | 356.58 | 371.16 | 333.08 | 324.16 | 309.58 | 300.66 |
EMA & SMA
400.85
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 351.93
9 Day 348.87
10 Day 347.32
12 Day 349.06
14 Day 350.39
20 Day 354.83
26 Day 351.95
50 Day 365.96
100 Day 374.66
200 Day 353.92
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 02 Dec, 2024 | ₹447.31 | 10,70,312 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 02 Dec, 2024 | ₹447.18 | 10,70,312 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 09 Sept, 2024 | ₹373.54 | 6,67,637 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 09 Sept, 2024 | ₹373.17 | 6,67,637 | NSE |
CYBAGE SOFTWARE PRIVATE LIMITED | block | Sell | 15 Mar, 2023 | ₹297.00 | 6,14,385 | NSE |
RITU ARUN NATHANI | block | Buy | 15 Mar, 2023 | ₹297.00 | 6,14,385 | NSE |
SMALLCAP WORLD FUND INC | bulk | Sell | 29 Jun, 2022 | ₹249.02 | 25,00,000 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
29 Dec, 2022 | Ashok Vishwanath Hiremath | Acquisition | ₹354.37 | 12,622 | NSE |
29 Dec, 2022 | Ashok Vishwanath Hiremath | Acquisition | ₹359.06 | 28,540 | NSE |
29 Dec, 2022 | Ashok Vishwanath Hiremath | Acquisition | ₹354.47 | 5,600 | NSE |
26 Dec, 2022 | Ashok Vishwanath Hiremath | Acquisition | ₹354.88 | 15,000 | NSE |
26 Dec, 2022 | Ashok Vishwanath Hiremath | Acquisition | ₹348.53 | 9,813 | NSE |
26 Dec, 2022 | Ashok Vishwanath Hiremath | Acquisition | ₹351.57 | 28,425 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
04 Feb, 2025 | Rs.0.6000 per share(30%)Interim Dividend | 07 Feb, 2025 | 08 Feb, 2025 |
09 May, 2024 | Rs.0.6000 per share(30%)Final Dividend (BC dates changed as RD and XD also revised) | 04 Sept, 2024 | 04 Sept, 2024 |
08 Feb, 2024 | Rs.0.6000 per share(30%)Interim Dividend | 20 Feb, 2024 | 20 Feb, 2024 |
Announcements
Date | Source | Detail |
---|---|---|
24 Mar, 2025 | NSE India | Hikal Limited has informed the Exchange about Closure of Trading Window |
24 Mar, 2025 | NSE India | Hikal Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
10 Feb, 2025 | NSE India | Hikal Limited has informed the Exchange about Transcript of earnings call held on February 4, 2025. |
10 Feb, 2025 | BSE India | Submission of transcript of earnings call held on February 4, 2025 |
08 Feb, 2025 | BSE India | Intimation under Regulation 30 of SEBI(LODR) Regulations, 2015 - TDS Communication regarding Interim dividend 2024-25 |
08 Feb, 2025 | NSE India | Hikal Limited has informed the Exchange regarding ''Intimation under Regulation 30 of SEBI Listing Regulations, 2015 Communication sent to shareholders regarding Tax Deduction at Source (TDS) on dividend income''. |
08 Feb, 2025 | BSE India | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
08 Feb, 2025 | NSE India | Hikal Limited has informed the Exchange regarding ''Intimation under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015''. |
06 Feb, 2025 | NSE India | HIKAL LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 04-Feb-2025 for Dividend |
05 Feb, 2025 | NSE India | Hikal Limited has informed the Exchange about Copy of Newspaper Publication for unaudited standalone and consolidated financial results for the quarter and period ended December 31, 2024 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Interim Dividend | -- | 30 Jan, 2025 | 04 Feb, 2025 |
Quarterly Results | -- | 06 Nov, 2024 | 12 Nov, 2024 |
Quarterly Results | -- | 23 Jul, 2024 | 01 Aug, 2024 |
Audited Results & Final Dividend | -- | 07 May, 2024 | 09 May, 2024 |
Quarterly Results & Interim Dividend | -- | 05 Feb, 2024 | 08 Feb, 2024 |
Quarterly Results | -- | 26 Oct, 2023 | 02 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
Audited Results & Final Dividend | -- | 24 May, 2023 | 29 May, 2023 |
Quarterly Results & Interim Dividend | -- | 26 Jan, 2023 | 02 Feb, 2023 |
Quarterly Results | -- | 03 Nov, 2022 | 09 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 68.85% | 68.85% | 68.83% | 68.77% | 68.77% |
Foreign Institutions + | 6.06% | 6.14% | 4.4% | 6.91% | 4.91% |
Domestic Institutions + | 3.48% | 3.15% | 1.57% | 0.38% | 0.68% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 21.61% | 21.86% | 25.2% | 23.94% | 25.64% |
Others | 0% | 0% | 0% | 0% | 0% |
About Hikal
Hikal is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1784.60 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Kalyani Group
Founded
1988
Managing Director
Mr. Sameer Hiremath
NSE Symbol
HIKAL
Hikal Management
Name | Designation |
---|---|
Mr. Jai Hiremath | Executive Chairman |
Mr. Sameer Hiremath | Managing Director |
Mr. Sarangan Suresh | Whole Time Director |
Ms. Sugandha Hiremath | Non Executive Director |
Mr. Amit Kalyani | Non Executive Director |
Mrs. Shivani Bhasin Sachdeva | Ind. Non-Executive Director |
Mr. Shrikrishna Adivarekar | Ind. Non-Executive Director |
Mr. Ramachandra Kaundinya | Ind. Non-Executive Director |
Mr. Berjis Desai | Ind. Non-Executive Director |
Mr. Ravi Kapoor | Ind. Non-Executive Director |
Mr. Ranjana S Salgaocar | Ind. Non-Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,24,682.29 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,52,989.54 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,556.300 - ₹6,448.750 |
Cipla | ₹1,20,795.29 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,09,916.93 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,00,161.69 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Hikal
What is the share price of Hikal?
The share price of Hikal on 04 Apr, 2025 is ₹ 400.85.
What is 52W high and 52W low share price of Hikal?
The highest and lowest 52W share prices of Hikal are ₹ 464.500 and ₹ 268.050
What is the market cap of Hikal?
The market capitalization of Hikal as of 04 Apr, 2025 is ₹ 4,942.51 Crores
What is the P/E ratio of Hikal?
The current P/E ratio of Hikal as of 04 Apr, 2025 is 46.49
What is the PB ratio of Hikal?
The PB ratio of Hikal as of 04 Apr, 2025 is 4.16
Top Gainers
₹109.04
₹90.87 (0.20%)
₹75.34
₹62.79 (0.20%)
₹143.15
₹119.30 (0.20%)
₹3.81
₹3.18 (0.20%)
Top Losers
₹3,206.90
₹3,774.25 (-0.15%)
₹28.50
₹32.80 (-0.13%)
₹950.60
₹1,188.25 (-0.20%)
₹753.20
₹889.55 (-0.15%)
Market Indices
Sensex
₹76,295.36
₹76,617.44 (0.00%)